A unit of generic drug maker Mylan has settled with Sunovion Pharmaceuticals over a drug used to treat chronic obstructive pulmonary disease and asthma.
More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.
A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.
A drug from Boehringer Ingelheim and Pfizer will retain Decision Resources’ status as a gold...